Second Half Financial Partners’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-10,591
Closed -$3.41M 95
2024
Q3
$3.41M Buy
+10,591
New +$3.46M 1.81% 14
2024
Q2
Sell
-18,925
Closed -$5.38M 44
2024
Q1
$5.38M Buy
+18,925
New +$5.54M 2.39% 19
2023
Q3
Sell
-11,385
Closed -$2.53M 45
2023
Q2
$2.53M Buy
+11,385
New +$2.64M 0.58% 60
2022
Q3
Sell
-15,711
Closed -$3.91M 38
2022
Q2
$3.91M Hold
15,711
3.01% 13
2022
Q1
$3.91M Buy
+15,711
New +$3.61M 3.01% 13

Other funds holding AMGN

Second Half Financial Partners's AMGN Position: Q4 2024 in Review

Second Half Financial Partners sold out of Amgen (AMGN) in Q4 2024, closing a stake of 10,591 shares — an estimated $3.41M sold.

Second Half Financial Partners first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $5.38M in Q1 2024. 2,856 funds tracked by Wall St. Rank hold AMGN as of Q4 2024.

  • Second Half Financial Partners reported no remaining Amgen position as of Q4 2024 after selling out during the quarter.
  • Second Half Financial Partners sold 10,591 Amgen shares in Q4 2024, an estimated $3.41M.
  • Second Half Financial Partners first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
  • Second Half Financial Partners's Amgen position peaked at $5.38M in Q1 2024.
  • 2,856 funds tracked by Wall St. Rank held Amgen as of Q4 2024.

Based on Second Half Financial Partners's 13F filing for Q4 2024, filed 14 Feb 2025.